future of compounded tirzepatide to Treat Diabetes Compound Tirzepatide

Adam Perlman, MD, MPH, who is the former director of Integrative Health and Wellbeing at the Mayo Clinics Florida campus and former associate vice president for health and wellness at the Duke University Health System

Disclaimer This article is for general education only and is not a substitute for personal medical advice, diagnosis, or treatment

Contact your healthcare provider if the coldness never goes away, or you have other warning signs of low blood sugar or decreased sensation in your hands and feet

Add 1,000 L (1 mL) of reconstitution solvent to the 1 mg vial This yields a 1 mg/mL (1,000 g/mL) stock solution To achieve 100 g/mL working stock: Dilute 100 L of 1 mg/mL stock into 900 L of PBS or cell culture medium yields 100 g/mL in 1 mL To achieve 10 ng/mL in a 5 mL experiment: Take 0.5 L of 100 g/mL working stock + 4,999.5 L of medium Alternatively: dilute to an intermediate concentration to reduce pipetting error Use a dilution series approach (stock working stock final experimental concentration) to minimize pipetting inaccuracy at nanogram-level concentrations